Acaone 100 mg Capsule
Brand Name: Acaone
Molecule: Acalabrutinib
Strength: 100 mg
Quantity: 30 Capsules
Form: Capsule
Packaging Type: Bottle
Manufacturer/Marketed By: Msn Laboratories India
Country of Origin: India
Please fill in the details below, and we’ll get back to you as soon as possible
Similar Products:
Benefits
-
Offers a targeted approach to treating certain B-cell malignancies.
-
Oral capsule formulation provides convenience compared to many IV therapies.
-
Can slow disease progression and improve clinical outcomes in eligible patients.
-
May improve quality of life by reducing disease burden when used appropriately.
Indications and Usage
-
Treatment of Mantle Cell Lymphoma (MCL) in adults who have received at least one prior therapy.
-
Treatment of Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) in adults.
Use only when prescribed by a qualified oncologist and in accordance with diagnostic testing and monitoring.
How it Works
Acalabrutinib blocks the Bruton Tyrosine Kinase (BTK) enzyme, which cancerous B-cells need to survive and multiply. By inhibiting BTK, it disrupts cancer cell signaling, slowing tumor growth and helping control disease progression.
Dosage & Administration
-
Usual dose: 100 mg capsule twice daily, or as prescribed
-
Swallow whole, with or without food
-
Take at the same time each day
-
Do not crush, chew, or break the capsule
-
Do not skip or stop doses without consulting the oncologist
-
Requires routine blood tests and clinical monitoring
Side Effects
Common side effects:
-
Headache
-
Diarrhea
-
Fatigue
-
Muscle pain
-
Easy bruising
Serious side effects:
-
Severe bleeding
-
Infections
-
Irregular heartbeat
-
Secondary cancers
-
Low blood cell count
Seek immediate medical attention for severe reactions.
Warning and Precaution
-
Not recommended during pregnancy or breastfeeding
-
Use caution in patients with bleeding disorders or heart conditions
-
Avoid live vaccines during treatment
-
Inform doctor about blood thinners or ongoing medications
-
Increased risk of infections — report fever immediately
-
Not for self-administration or over-the-counter use
Related Products
Related Posts:
Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another
READ MORE »May 18, 2026
Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026.n n This marks an important
READ MORE »May 14, 2026
FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026.n n Brain tumors, especially high-grade
READ MORE »April 14, 2026
Only logged in customers who have purchased this product may leave a review.
Reviews
Clear filtersThere are no reviews yet.